Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of blood purification and replacement fluid, which is applied in the direction of blood diseases, extracellular fluid diseases, active ingredients of alkali/alkaline earth metal chlorides, etc., to reduce the risk of configuration contamination, stabilize the internal environment of the body, and simplify the configuration of replacement fluid.
Inactive Publication Date: 2010-12-15
宋青 +3
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] The purpose of the present invention is to provide a blood purification basic replacement solution that can meet the continuous blood purification treatment needs of critically ill patients, which not only overcomes the need for ready-to-use at the bedside Disadvantages such as pollution and cumbersome configuration process brought by the replacement fluid are also convenient for the rapid configuration of bicarbonate in clinical practice, without causing complications such as lactic acidosis and hyperglycemia, and stabilizing the internal environment of the body to the greatest extent
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0012] Take NaCl 27g, MgSO 4 0.8g and CaCl 2 1g, dissolved in an appropriate amount of water for injection, according to the conventional preparation method of large infusion, after stirring, initial filtration, adding water for injection to a total volume of 4000ml, after terminal filtration, filled in medical plastic infusion bags, sealed and sterilized.
[0013] Example 2 (hypotonic base replacement fluid)
Embodiment 2
[0014] Take NaCl 24.3g, MgSO 4 0.88g and CaCl 2 1.1g, dissolved in an appropriate amount of water for injection, according to the conventional preparation method of large infusion, after stirring, initial filtration, adding water for injection to a total volume of 4000ml, after terminal filtration, filled in medical plastic infusion bags, sealed, and sterilized.
[0015] Example 3 (hypertonic base replacement fluid)
Embodiment 3
[0016] Take NaCl 29.7g, MgSO 4 0.72g and CaCl 2 0.9g, dissolved in an appropriate amount of water for injection, according to the conventional preparation method of large infusion, after stirring, initial filtration, adding water for injection to a total volume of 4000ml, after terminal filtration, filled in medical plastic infusion bags, sealed, and sterilized.
[0017] Example 4 (half sugar base replacement solution)
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses blood purification base displacing liquid. Each hundred milliliter of water for injection contains 607.5 to 742.5 milligrams of NaCl, 18 to 22 milligrams of MgSO4 and 22.5 to 27.5 milligrams of CaCl2 which form sugar-free base displacing liquid. Based on a formula of the sugar-free base displacing liquid, 625 to 1,250 milligrams of glucose is added to form sugar-containing base displacing liquid. The blood purification base displacing liquid can meet the requirement of serious patients for continuous blood purification treatment, overcomes the defects of pollution and fussy preparation process caused by preparing the ready-to-use displacing liquid beside a bed, facilitates quick preparation of clinical bicarbonate, realizes personalized treatment, and can effectively avoid complications such as hyperkalemia, lactic acidosis, hyperglycemia and the like and furthest stabilize the internal environment of the patient body.
Description
technical field [0001] The invention belongs to the technical field of medicine manufacturing and relates to a basic replacement fluid, in particular to a blood purification basic replacement fluid suitable for metabolic disorders in the body. Background technique [0002] For critically ill patients, especially patients with multiple organ dysfunction syndrome (MODS) in the intensive care unit (ICU), continuous blood purification (CBP) has been used in recent years , CBP) technology, which removes the damage factors involved in the occurrence and development of MODS in the blood, down-regulates the inflammatory response, and improves the prognosis of MODS, has gradually become one of the effective methods for the treatment of MODS. [0003] In the continuous blood purification technology, on the one hand, the replacement fluid acts as a carrier for removing substances to remove metabolites and poisons in the body, and on the other hand, it can supplement the substances lac...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more